Christopher Ruane examines a trio of FTSE 100 shares that he reckons might push the index higher. For now, though, he won't be buying one of them. Why not?

Dalton Del Don reveals why you have to look deeper than the surface-level stats to appreciate what some pitchers can offer your fantasy team.

Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...

Janus Henderson Mortgage-Backed Securities ETF returned 3.01% and the Bloomberg U.S. Mortgage Backed Securities (MBS) Index ...

Rocket Lab remains a top growth stock pick, with strong Q1 results, robust launch demand, and a growing backlog. Read the ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued ...

Primarily, the METU and METD ETFs offer a convenient medium for speculation. Typically, those interested in leverage or short wagers must engage the options market, an arena known for its myriad ...

In terms of visitors, Kogan.com averages some 5 million monthly site visits compared with about 70 million for Amazon.com.au, according to Similarweb. We estimate the Australian sales differential to ...

Chirag Muni explains how the Information Ratio helps investors assess the efficiency of active fund managers by comparing ...

Google's AIO not only shows spam but also rewrites content without adding analysis or insights, which are hallmarks of ...

Opinion: IP experts Christine McCarthy, Molly Sigler, and Gurpeet Kaur say intellectual property can be a valuable asset for ...

"The combination of diminished appetite to buy U.S. assets and the rigidity of a U.S. fiscal process that locks in very high ...